Page last updated: 2024-11-02

pipobroman and Enlarged Spleen

pipobroman has been researched along with Enlarged Spleen in 6 studies

Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.

Research Excerpts

ExcerptRelevanceReference
"An analysis of the risk of progression towards leukemia, carcinoma and myelofibrosis was performed in 93 patients treated by 32P alone (PVSG protocols) since 1970-1979, 395 patients over the age of 65 years treated by 32P with or without maintenance therapy using hydroxyurea (French protocol) since 1980-1994, and 202 patients under the age of 65 treated by either hydroxyurea or pipobroman since 1980."6.18Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias". ( Dresch, C; Echard, M; Goguel, A; Grange, MJ; Lejeune, F; Najean, Y; Rain, JD, 1996)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rain, JD2
Boivin, P2
Najean, Y1
Dresch, C1
Goguel, A1
Lejeune, F1
Echard, M1
Grange, MJ1
Jamshidi, K1
Ansari, A1
Windschitl, HE1
Swaim, WR1
Bilski-Pasquier, G1
Blanc, CM1
Bousser, J1
Vallée, G1
Dormont, J1
Soulier, JP1

Reviews

2 reviews available for pipobroman and Enlarged Spleen

ArticleYear
[Polycythemia vera].
    La Revue du praticien, 2002, Oct-15, Volume: 52, Issue:16

    Topics: Aged; Diagnosis, Differential; Erythrocyte Count; Female; Hematocrit; Humans; Hydroxyurea; Male; Mid

2002
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Leukemia & lymphoma, 1996, Volume: 22 Suppl 1

    Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies

1996

Trials

2 trials available for pipobroman and Enlarged Spleen

ArticleYear
Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
    Nouvelle revue francaise d'hematologie, 1993, Volume: 35, Issue:5

    Topics: Acute Disease; Bloodletting; Combined Modality Therapy; Humans; Hydroxyurea; Leukemia; Phosphorus Ra

1993
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
    Leukemia & lymphoma, 1996, Volume: 22 Suppl 1

    Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies

1996

Other Studies

3 other studies available for pipobroman and Enlarged Spleen

ArticleYear
Primary thrombocythemia.
    Geriatrics, 1973, Volume: 28, Issue:1

    Topics: Adult; Aged; Blood Coagulation Tests; Bone Marrow Examination; Busulfan; Follow-Up Studies; Gastroin

1973
[Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases].
    La Presse medicale, 1968, Oct-26, Volume: 76, Issue:41

    Topics: Aged; Antineoplastic Agents; Bromine; Erythrocyte Count; Female; Humans; Leukemia, Myeloid; Leukopen

1968
[Present treatment of the Vaquez's disease].
    La Presse medicale, 1969, Mar-22, Volume: 77, Issue:14

    Topics: Aged; Anemia; Anticoagulants; Antineoplastic Agents; Blood Donors; Blood Volume; Bloodletting; Busul

1969